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Introduction
The term CAPS (cryopyrin-associated periodic syn-
dromes) identifies a spectrum of autoinflammatory dis-
eases caused by heterozygous mutations of the CIAS1/
NLRP3. Affected individuals may present three different
phenotypes: familial cold autoinflammatory syndrome
(FCAS), Muckle-Wells syndrome (MWS) and CINCA
syndrome, the most severe form of the clinical spectrum.
Clinical manifestations include urticaria-like rash,
recurrent fever, arthralgia, conjunctivitis; chronic aseptic
meningitis, cerebral atrophy and bone malformations in
the severe cases.
Objectives
To describe the long-term clinical course of a cohort of
patients carrying two different low-penetrance NLRP3
mutations (V198M and Q703K)
Methods
Six patients were identified carrying the NLRP3 V198M
mutation (mean age 10,35±4,73 years, 4 males and
2 females), and 5 patients were identified carrying the
NLRP3 Q703K (mean age 9,72±4,55 years,3 males and
2 female). All were Caucasians.
Results
In the V198M cohort the mean age at disease onset was
5,85±4,08 years. All patients had symptoms consistent
with recurrent inflammatory syndrome: 6/6 presented
recurrent episodes of skin lesions and arthralgia, 4/6 of
fever attacks, 3/6 of arthritis, 2/6 of headache and subcuta-
neous edema. One patient showed fatigue, conjunctivitis
and recurrent abdominal pain. Half of the patients had
a positive family history for recurrent inflammatory
episodes. In 3 out of 6 patients the severity of phenotype
and the persistence of elevated acute phase reactants, led
to initiation of anti IL-1 therapy with immediate benefit .
In the cohort of patients with Q703K variant the mean age
at disease onset was 3,73±3,33 years. All patients had skin
rash, 4/5 patients presented recurrent fever, 3/5 arthralgia
and myalgia, 2/5 subcutaneous edema, pharyngitis and
lymphadenitis; 1 patient had mild arthritis, headache and
abdominal pain. Only in 1 case, symptoms were triggered
or worsened by cold exposure. None of our patients had a
family history relevant for autoinflammatory symptoms.
Laboratory test showed no increase in acute phase reac-
tants, with one exception. This patient presented also with
recurrent fevers, treatment resistant epilepsy and carries
an heterozygous MEFV mutation. She failed colchicine
and anti IL-1 therapy was started.
Conclusion
The pathogenic significance of these NLRP3 mutations is
still discussed [2]. In our experience patients carrying
Q703K mutation appear to have a milder and self-limited
phenotype than those with V198M variant in which
therapy with IL-1 inhibitor drugs is often necessary. The
factors that affect the pathogenic consequences of these
variants are still to be established.
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